As of 30 Sep 2025, 1 institutional investors reported holding 3,051,990 shares of BIOPHARMA CREDIT PLC - COM.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 3,051,990 | $2,745,423 | +$449,800 | $0.90 | 1 |
| 2025 Q2 | 2,551,990 | $2,254,049 | +$693,318 | $0.88 | 1 |
| 2025 Q1 | 1,767,072 | $1,567,096 | +$203,107 | $0.89 | 1 |
| 2024 Q4 | 1,538,038 | $1,361,164 | +$147,606 | $0.88 | 1 |
| 2024 Q3 | 1,371,252 | $1,271,151 | $0 | $0.93 | 1 |
| 2024 Q2 | 1,371,252 | $907,922 | -$221,097 | $0.66 | 1 |
| 2024 Q1 | 1,705,185 | $1,179,747 | -$210,548 | $0.69 | 1 |
| 2023 Q4 | 2,009,489 | $1,704,047 | +$727,666 | $0.85 | 1 |
| 2023 Q3 | 1,151,392 | $793,226 | -$124,665 | $0.69 | 1 |
| 2023 Q2 | 1,332,354 | $1,192,457 | -$517,354 | $0.90 | 1 |
| 2023 Q1 | 1,910,403 | $1,836,736 | +$75,193 | $0.96 | 1 |
| 2022 Q4 | 1,832,191 | $1,749,135 | +$746,758 | $0.95 | 1 |
| 2022 Q3 | 1,050,000 | $975,500 | +$975,450 | $0.93 | 1 |